Thromb Haemost 1970; 23(02): 202-210
DOI: 10.1055/s-0038-1654135
Originalarbeiten – Original Articles – Travaux Originaux
Schattauer GmbH

The Preparation and Evaluation of a Standardized Fibrin Plate[+] for the Assessment of Fibrinolytic Activity

R Bishop B. A.*
,
H Ekert M.B., M.R.A.C.P.**
,
G Gilchrist M.B., D.C.H.**
,
E Shanbrom M.D.*
,
L Fekete B.S.*
Supported in part by the Medical Research Committee of Delta Delta Delta and by Public Health Grant TIHD 48.
Further Information

Publication History

Publication Date:
27 June 2018 (online)

Summary

A new fibrin plate technic for evaluating components of the fibrinolytic system has been developed. It provides quick, accurate, and easily interpreted results for the fibrinolytic profile. The standardized human plasminogen-free fibrin plates can be produced in bulk and stored for prolonged periods of time. A test specimen placed in a well punched in the buffered agarose gel diffuses into the agar and lyses the fibrin clot, forming a clear reaction zone. The zone diameter is directly proportional to the log of the percent concentration of available fibrinolytic enzyme in the specimen. The plates may be used to quantitate total plasminogen, and estimate available plasmin and active plasmin. A good correlation between results obtained using these fibrin plates and caseinolytic methods was found. Performance and interpretation of tests of fibrinolysis done on these new fibrin plates indicate that it may be the most sensitive technic available for clinical laboratory work.

+ Patents pending.


* Research Division, HYLAND Division Travenol Laboratories, Inc., Costa Mesa, California 92626.


** Childrens Hospital, Los Angeles, California.


 
  • References

  • 1 Pechet L. Fibrinolysis. New Engl. J. Med 273: 1024 1965;
  • 2 Astrup T, Mullertz S. The fibrin plate method for estimating fibrinolytic activity. Arch. Biochem 40: 346 1952;
  • 3 Brackman P. Fibrinolysis: A Standardized Fibrin Plate Method and a Fibrinolytic Assay of Plasminogen. Scheltema and Holkema; Amsterdam: 1967
  • 4 Maxwell R. E, Nickel V. S, Lewandowski U. Preparations of plasminogen-deficient fibrinogen and thrombin. Biochem. biophys. Res. Commun 7: 50 1962;
  • 5 Fletcher A. P, Biederman O, Moore D, Alkjaersig N, Sherry S. Abnormal plasminogen-plasmin system activity (fibrinolysis) in patients with hepatic cirrhosis : its causes and consequences. J. clin. Invest 43: 681 1964;
  • 6 Alkjaersig N, Fletcher A. P, Sherry S. E-Aminocaproic acid: an inhibitor of plasminogen activation. J. biol. Chem 234: 832 1959;
  • 7 Sgouris J. T, Inman J. K, McCall K. B, Hyndman L. A, Anderson H. D. The preparation of human fibrinolysin (plasmin). Vox Sang 5: 357-376 1960;